Navigation Links
Allergy Shots Are Effective Treatment for Symptoms
Date:1/26/2008

Immunotherapy works for allergic asthma, rhinitis, conjunctivitis or insect bites

SATURDAY, Jan. 26 (HealthDay News) -- If you have allergic asthma, rhinitis, conjunctivitis or stinging insect allergies, you may be a good candidate for allergy shots, also known as immunotherapy.

That's the recommendation of the American Academy of Allergy, Asthma & Immunology.

"Immunotherapy is a form of treatment that aims to decrease sensitivity to substances called allergens," Dr. Linda Cox, chair of the AAAAI's Immunotherapy and Allergy Diagnostics Committee, said in a prepared statement.

"Allergens, like pollen, mold or animal dander, are substances that trigger allergy symptoms when an allergic person is exposed to them. Patients who receive immunotherapy are injected with increasing amounts of an allergen until the target therapeutic dose is reached, in an effort to build resistance to specific allergens," Cox explained.

She said relief of allergy symptoms can last long after completion of treatment and that immunotherapy helps prevent the development of new allergies and may prevent the progression of allergic rhinitis to asthma.

Immunotherapy involves injections of gradually increasing doses of a particular allergen. Your body responds by developing immunity or tolerance to the allergen, resulting in decreased symptoms when you're exposed to the allergen.

While immunotherapy is recommended for people with allergic asthma, rhinitis, conjunctivitis and stinging insect allergies, it's not recommended for those with food allergies, the AAAAI said. The best option for people with food allergies is to avoid foods that pose a danger.

The AAAAI says people should see a doctor about immunotherapy if they:

  • Have a clear relationship between asthma, rhinitis, conjunctivitis, and exposure to an allergen,
  • Have a poor response to allergy medication or avoidance measures,
  • Have a long duration of allergy symptoms (most of the year),
  • Are a child with rhinitis, because of the potential role of allergen immunotherapy in the progression of allergic disease.

More information

To learn more, visit the American Academy of Allergy, Asthma & Immunology.



-- Robert Preidt



SOURCE: American Academy of Allergy, Asthma & Immunology, news release, January 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic OTC Versions of Childrens Zyrtec(R) Chewable Tablets for Allergy Relief and Childrens Zyrtec(R) Chewable Tablets for Hives Relief
2. A Few Shots Away: Immunotherapy May Relieve Allergy Symptoms
3. Protein a possible key to allergy and asthma control
4. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic OTC Versions of Zyrtec Allergy Tablets(R) and Zyrtec Hives Relief Tablets(R)
5. Parents Smoking Boosts Childs Allergy Risk
6. Menopausal Women May Have an Increased Asthma Risk, From The Journal of Allergy and Clinical Immunology
7. Allergy Foundation Thinks Globally, Gifts Locally
8. Tis the Season For Allergy, Asthma
9. FDA Approves the Allergy Treatment Zyrtec(R) for Use Without a Prescription
10. Austin Named the New Fall Allergy Capital
11. Breast-Feeding Cuts Food Allergy Risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/20/2017)... ... ... Houston, Texas, investment firm CORDA Investment Management, LLC, believes in giving back. ... work and rolled up their sleeves to help with relief efforts. The team picked ... process of rebuilding. , CORDA founder Bonner C. Barnes notes that investment management firms ...
(Date:9/20/2017)... ... September 20, 2017 , ... “The Financial Favor of God; Second ... of God; Second Edition” is the creation of published author, Brooks Rathell. , “We ... to talk to you about the financial favor of God. Not only does it ...
(Date:9/19/2017)... ... September 19, 2017 , ... Only a few physicians were ... Brevard’s own Ross A. Clevens, MD, FACS . The founder and medical director ... and Reconstructive Surgeon who trained at Yale, Harvard and the University of Michigan. He ...
(Date:9/19/2017)... ... September 19, 2017 , ... ... for the President’s Malaria Initiative (PMI) Africa Indoor Residual Spraying (AIRS) Project ... Award. , The Innovation to Action Award, a USAID Catalyst Award, recognizes ...
(Date:9/19/2017)... ... September 19, 2017 , ... The American College ... to its recently formed Corporate Roundtable, a group of individuals and organizations whose ... world. , Canyon Ranch is a unique collection of lifestyle-based immersion vacation settings ...
Breaking Medicine News(10 mins):
(Date:9/5/2017)...  Just 18 months after its February 2016 launch, ... the appointment of three new senior people to its ... Jones-Phillips and James Wright bring decades ... Tammy Wynne joins as Director, ... She has over ten years, experience in global market ...
(Date:9/1/2017)... Sept. 1, 2017 Michael Penna , ... , highlights opportunities for growth in his response to ... Marlin Equity is seeking a buyer for eMDs. Penna,s ... 22-year-old healthcare solutions Value Added Reseller and national leader ... "As the healthcare market continues to ...
(Date:9/1/2017)... , Sept. 1, 2017  Bayer will present the ... European Society for Medical Oncology (ESMO) 2017 Congress, September 8-12 ... will include new preclinical and clinical data on Bayer,s marketed ... earlier pipeline projects. ... best minds in cancer research at ESMO," said Carsten ...
Breaking Medicine Technology: